XML 11 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Balance at Dec. 31, 2022 $ 68,562 $ 177 $ 1,077,341 $ (2,787) $ (1,007,121) $ 952
Balance (in shares) at Dec. 31, 2022   177,582        
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 426 $ 3 423      
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   2,890        
Stock-based compensation 5,669   5,669      
Other comprehensive income 546     546    
Net loss (15,641)       (15,619) (22)
Balance at Mar. 31, 2023 59,562 $ 180 1,083,433 (2,241) (1,022,740) 930
Balance (in shares) at Mar. 31, 2023   180,472        
Balance at Dec. 31, 2023 53,444 $ 181 1,098,353 (1,274) (1,044,610) 794
Balance (in shares) at Dec. 31, 2023   181,248        
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 401 $ 4 397      
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   3,565        
Stock-based compensation 5,855   5,855      
Other comprehensive income 152     152    
Net loss (9,690)       (9,688) (2)
Balance at Mar. 31, 2024 $ 50,162 $ 185 $ 1,104,605 $ (1,122) $ (1,054,298) $ 792
Balance (in shares) at Mar. 31, 2024   184,813